206 related articles for article (PubMed ID: 6086210)
1. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist.
Baraldi M; Zeneroli ML; Ventura E; Penne A; Pinelli G; Ricci P; Santi M
Clin Sci (Lond); 1984 Aug; 67(2):167-75. PubMed ID: 6086210
[TBL] [Abstract][Full Text] [Related]
2. Hepatic encephalopathy. Experimental studies in a rat model of fulminant hepatic failure.
Zeneroli ML
J Hepatol; 1985; 1(3):301-11. PubMed ID: 2999224
[TBL] [Abstract][Full Text] [Related]
3. A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding.
Zieve L; Ferenci P; Rzepczynski D; Ebner J; Zimmermann C
Metab Brain Dis; 1987 Sep; 2(3):201-5. PubMed ID: 2850457
[TBL] [Abstract][Full Text] [Related]
4. Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure.
Schafer DF; Fowler JM; Munson PJ; Thakur AK; Waggoner JG; Jones EA
J Lab Clin Med; 1983 Dec; 102(6):870-80. PubMed ID: 6315836
[TBL] [Abstract][Full Text] [Related]
5. Benzodiazepine receptor ligands are elevated in an animal model of hepatic encephalopathy: relationship between brain concentration and severity of encephalopathy.
Yurdaydin C; Gu ZQ; Nowak G; Fromm C; Holt AG; Basile AS
J Pharmacol Exp Ther; 1993 May; 265(2):565-71. PubMed ID: 8388453
[TBL] [Abstract][Full Text] [Related]
6. Experimental hepatic encephalopathy: changes in the binding of gamma-aminobutyric acid.
Baraldi M; Zeneroli ZL
Science; 1982 Apr; 216(4544):427-9. PubMed ID: 6280279
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
Bassett ML; Mullen KD; Skolnick P; Jones EA
Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828
[TBL] [Abstract][Full Text] [Related]
8. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands.
Gammal SH; Basile AS; Geller D; Skolnick P; Jones EA
Hepatology; 1990 Mar; 11(3):371-8. PubMed ID: 2155865
[TBL] [Abstract][Full Text] [Related]
9. Increased benzodiazepine-like activity is neither necessary nor sufficient to explain acute hepatic encephalopathy in the thioacetamide-treated rat.
Widler P; Fisch HU; Schoch P; Zimmermann A; Schläpfer TE; Reichen J
Hepatology; 1993 Dec; 18(6):1459-64. PubMed ID: 8080486
[TBL] [Abstract][Full Text] [Related]
10. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.
Basile AS; Hughes RD; Harrison PM; Murata Y; Pannell L; Jones EA; Williams R; Skolnick P
N Engl J Med; 1991 Aug; 325(7):473-8. PubMed ID: 1649403
[TBL] [Abstract][Full Text] [Related]
11. Evidence that 2-phenylpyrazolo[4,3-c]-quinolin-3(5H)-one antagonises pharmacological, electrophysiological and biochemical effects of diazepam in rats.
Santi M; Pinelli G; Ricci P; Penne A; Zeneroli ML; Baraldi M
Neuropharmacology; 1985 Feb; 24(2):99-105. PubMed ID: 2986034
[TBL] [Abstract][Full Text] [Related]
12. Effect of taurine on a benzodiazepine-GABA-chloride ionophore receptor complex in rat brain membranes.
Iwata H; Nakayama K; Matsuda T; Baba A
Neurochem Res; 1984 Apr; 9(4):535-44. PubMed ID: 6087177
[TBL] [Abstract][Full Text] [Related]
13. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA
Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320
[TBL] [Abstract][Full Text] [Related]
14. NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances.
Jones EA; Skolnick P; Gammal SH; Basile AS; Mullen KD
Ann Intern Med; 1989 Apr; 110(7):532-46. PubMed ID: 2538099
[TBL] [Abstract][Full Text] [Related]
15. Increased brain concentrations of endogenous (non-benzodiazepine) GABA-A receptor ligands in human hepatic encephalopathy.
Ahboucha S; Pomier-Layrargues G; Butterworth RF
Metab Brain Dis; 2004 Dec; 19(3-4):241-51. PubMed ID: 15554420
[TBL] [Abstract][Full Text] [Related]
16. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
Mullen KD; Martin JV; Mendelson WB; Bassett ML; Jones EA
Lancet; 1988 Feb; 1(8583):457-9. PubMed ID: 2893876
[TBL] [Abstract][Full Text] [Related]
17. Benzodiazepine binding and interactions with the GABA receptor complex in living cultures of rat cerebral cortex.
White WF; Dichter MA; Snodgrass SR
Brain Res; 1981 Jun; 215(1-2):162-76. PubMed ID: 6114777
[TBL] [Abstract][Full Text] [Related]
18. Characterization of benzodiazepine and gamma-aminobutyric recognition sites and their endogenous modulators.
Massotti M; Guidotti A; Costa E
J Neurosci; 1981 Apr; 1(4):409-18. PubMed ID: 6267225
[TBL] [Abstract][Full Text] [Related]
19. Functional interaction between benzodiazepine and GABA recognition sites in aged rats.
Calderini G; Bonetti AC; Aldinio A; Savoini G; Di Perri B; Biggio G; Toffano G
Neurobiol Aging; 1981; 2(4):309-13. PubMed ID: 6278346
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of benzodiazepine and GABA binding by the novel anxiolytic, tracazolate.
Meiners BA; Salama AI
Eur J Pharmacol; 1982 Mar; 78(3):315-22. PubMed ID: 6121710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
